BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21454319)

  • 1. Delirium in palliative care patients: focus on pharmacotherapy.
    Zimmerman K; Rudolph J; Salow M; Skarf LM
    Am J Hosp Palliat Care; 2011 Nov; 28(7):501-10. PubMed ID: 21454319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of hydration in delirium at the end of life.
    Galanakis C; Mayo NE; Gagnon B
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):169-73. PubMed ID: 21532351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delirium in palliative care].
    Loge JH; Hjermstad MJ; Kaasa S
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):616-9. PubMed ID: 16505874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment and management of delirium in cancer patients.
    Bush SH; Bruera E
    Oncologist; 2009 Oct; 14(10):1039-49. PubMed ID: 19808772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delirium in patients with cancer].
    Staniszewska A; Kłoszewska I
    Wiad Lek; 2007; 60(1-2):60-3. PubMed ID: 17607970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Opioids, Steroids, Benzodiazepines, Anticholinergics, and Antihistamines on the Efficacy of Antipsychotics for Treating Delirium in End-of-Life Adult Patients Undergoing Palliative Care.
    Sato J; Tanaka R
    J Pain Palliat Care Pharmacother; 2023 Dec; 37(4):298-307. PubMed ID: 37702451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials.
    Gaertner J; Eychmueller S; Leyhe T; Bueche D; Savaskan E; Schlögl M
    Ann Palliat Med; 2019 Sep; 8(4):504-515. PubMed ID: 30943743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-based delirium treatment approaches].
    Hammann F; Drewe J
    Ther Umsch; 2010 Feb; 67(2):91-4. PubMed ID: 20131219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.
    Hui D
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):489-494. PubMed ID: 30239384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of delirium in the critically ill patient.
    Fish DN
    Clin Pharm; 1991 Jun; 10(6):456-66. PubMed ID: 1676622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core palliative medicines: meeting the needs of non-complex community patients.
    Tait P; Morris B; To T
    Aust Fam Physician; 2014; 43(1):29-32. PubMed ID: 24563890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effects of the pharmacological and nonpharmacological interventions to manage delirium symptoms in palliative care patients: systematic review.
    Skelton L; Guo P
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):384-391. PubMed ID: 31490322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delirium issues in palliative care settings.
    Leonard M; Agar M; Mason C; Lawlor P
    J Psychosom Res; 2008 Sep; 65(3):289-98. PubMed ID: 18707953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delirium in palliative care.
    Friedlander MM; Brayman Y; Breitbart WS
    Oncology (Williston Park); 2004 Oct; 18(12):1541-50; discussion 1551-3. PubMed ID: 15609476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of delirium education on use of target PRN medications in older orthopaedic patients.
    Hunter KF; Cyr D
    Age Ageing; 2007 Jan; 36(1):98-101. PubMed ID: 17114202
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea.
    Ross DD; Alexander CS
    Am Fam Physician; 2001 Sep; 64(6):1019-26. PubMed ID: 11578023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delirium in the elderly].
    Singler K; Singler B; Heppner HJ
    Dtsch Med Wochenschr; 2011 Apr; 136(14):681-4. PubMed ID: 21448826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma.
    Farrell H; Eastman P
    BMJ Support Palliat Care; 2013 Mar; 3(1):4-5. PubMed ID: 24644317
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential role of zuclopenthixol acetate in the management of refractory hyperactive delirium at the end of life.
    Tarumi Y; Watanabe S
    J Pain Symptom Manage; 2008 Apr; 35(4):336-9. PubMed ID: 18291620
    [No Abstract]   [Full Text] [Related]  

  • 20. Delirium at the End of Life.
    Agar M; Bush SH
    Med Clin North Am; 2020 May; 104(3):491-501. PubMed ID: 32312411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.